Related Experiment Video
Updated: Dec 24, 2025
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Molecular targets for the rational design of drugs to inhibit SARS coronavirus
Sarah M Brockway1,2, Mark R Denison1,2,3
1Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Abstract:
Despite years of research, the precise determinants of coronavirus replication and pathogenesis remain unidentified. What is known of the pathogenesis of the severe acute respiratory syndrome coronavirus (SARS-CoV) is limited, but clinical observations suggest that both viral-induced cytotoxicity and host immune-mediated destruction contribute to the severity of disease. This summary discusses recent advances in coronavirus research that will facilitate the identification of crucial molecular targets for the rational design of SARS therapeutics.
Insights
Research continues to identify key factors in coronavirus replication and disease severity. Understanding these molecular targets is crucial for developing effective severe acute respiratory syndrome (SARS) therapeutics.
Area of Science:
- Virology
- Immunology
- Pathogenesis
Background:
- The precise determinants of coronavirus replication and pathogenesis are not fully understood.
- Knowledge of severe acute respiratory syndrome coronavirus (SARS-CoV) pathogenesis is limited.
- Clinical observations indicate viral cytotoxicity and host immune responses contribute to disease severity.
Purpose of the Study:
- To summarize recent advances in coronavirus research.
- To facilitate the identification of crucial molecular targets for SARS therapeutics.
Main Methods:
- Review of recent scientific literature on coronavirus research.
- Analysis of clinical observations regarding SARS-CoV pathogenesis.
Main Results:
- Recent advances provide new insights into coronavirus replication.
- Understanding of SARS-CoV pathogenesis is improving.
- Potential molecular targets for therapeutic intervention are emerging.
Conclusions:
- Continued research is essential for identifying critical molecular targets.
- Rational drug design for SARS therapeutics can be advanced through this research.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...